Epidermal growth factor enhances human AT1 receptor promoter activity, potentially via PEA3 transcription factor binding.
No takes yet. Share an insight, caveat, or question.
EGF-AT1 promoter interaction via PEA3 is hypothesis-generating; leaves open relevance to hypertension and need for in vivo validation.
Guo et al. (1994) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: